METROPOLITAN LIFE INSURANCE CO/NY - BRIDGEBIO PHARMA INC ownership

Back to all holdings Add to watchlist

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$175,044
+62.6%
6,638
+6.1%
0.01%
+80.0%
Q2 2023$107,638
+10.3%
6,258
+6.3%
0.01%0.0%
Q1 2023$97,590
+88.7%
5,886
-13.3%
0.01%
+150.0%
Q4 2022$51,725
-23.3%
6,7880.0%0.00%
-33.3%
Q3 2022$67,473
+9.5%
6,7880.0%0.00%0.0%
Q2 2022$61,635
-10.5%
6,7880.0%0.00%
+50.0%
Q1 2022$68,898
-84.6%
6,788
-74.8%
0.00%
-66.7%
Q4 2021$448,775
-66.4%
26,905
-5.5%
0.01%
-68.4%
Q3 2021$1,334,155
-25.4%
28,465
-3.0%
0.02%
-24.0%
Q2 2021$1,788,810
+14.0%
29,344
+15.2%
0.02%
+8.7%
Q1 2021$1,569,753
+5.1%
25,483
+21.3%
0.02%
+4.5%
Q4 2020$1,493,666
+89.5%
21,0050.0%0.02%
+57.1%
Q3 2020$788,108
+6.5%
21,005
-7.5%
0.01%
+7.7%
Q2 2020$740,149
+12.4%
22,6970.0%0.01%
-7.1%
Q1 2020$658,213
+150.6%
22,697
+202.9%
0.01%
+250.0%
Q4 2019$262,665
+13.0%
7,494
-30.8%
0.00%0.0%
Q3 2019$232,520–10,830–0.00%–
 Download
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders